PAB18100

antibody from Abnova Corporation

Targeting: MAPKAPK2 MK2

Western blot (Supportive data in Antibodypedia)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

PAB18100

Provider

Abnova Corporation

Proper citation

Abnova Corporation Cat#PAB18100, RRID:AB_10715131

Product name

MAPKAPK2 polyclonal antibody

Antibody type

Polyclonal

Description

Rabbit polyclonal antibody raised against synthetic peptide of MAPKAPK2.

Storage

Store at -20°C.Aliquot to avoid repeated freezing and thawing.

References

Submitted references

ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells.

Miguel SM, Namdar-Attar M, Noh T, Frenkel B, Bab I
The Journal of biological chemistry 2005 Nov 11;280(45):37495-502

---

Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.

Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD
Circulation research 2000 Feb 4;86(2):144-51

Western blot

Supportive validation

Submitted by

Abnova Corporation (provider)

Main image

Experimental details

Western blot analysis of extracts from HeLa cells, treated with Ca₂₊ (40 nM, 30 mins), using MAPKAPK2 polyclonal antibody (Cat # PAB18100).Peptide "+" means "peptide blocking".

Immunohistochemistry

Supportive validation

Submitted by

Abnova Corporation (provider)

Main image

Experimental details

Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using MAPKAPK2 polyclonal antibody (Cat # PAB18100).Peptide "+" means "peptide blocking".

Validation comment

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)